Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on LSD-assisted psychotherapy for illness-related anxiety has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lysergic Acid Diethylamide (LSD)

Snippet

Sponsor: Multidisciplinary Association for Psychedelic Studies | Conditions: Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2021-12-08